Welcome to another edition of Core Biotech!I started this portfolio with the objective of proving that Long-Term investing in the biotech sector is a worthwhile endeavor.New buys and sells are ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min This week's roundup of life ...
PDS Biotech's Phase 2 study shows potential breakthrough in treating HPV16-positive head and neck cancer. The study shows a 87.1% 12-month survival rate for ICI naive patients, nearly doubling typical ...
* Fortress Biotech - On March 31, entered into note purchase agreements, sold subordinated promissory notes of co in principal amount of $3.25 million Source text: [bit.ly/2p6D2bA] Further company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results